{"entity":{"type":"insider","cik":"0001922189","url":"/insider/0001922189","json_url":"/insider/0001922189.json","name":"MGG Strategic SICAF SIF S.A.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":9,"n_filings":4,"first":"2022-09-16","last":"2022-12-05","span_basis":"filed_date"},"name_variants":[{"name":"MGG Strategic SICAF SIF S.A.","source":"filing","n_filings":4,"first_seen":"2022-09-16","last_seen":"2022-12-05"}],"transactions":[{"id":6604767,"accession":"0001140361-22-044471","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-22-044471","line_url":"/filing/0001140361-22-044471#line-2","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":null,"owner_name":"Avara Management Ltd; Giuliani Mario Germano; MGG Strategic SICAF SIF S.A.; MGG Strategic SICAF SIF S.A. - MGG Strategic; Skyeline Management Ltd","owner_display_name":"Avara Management Ltd","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":197766.0,"shares_display":"197,766","price_per_share":43.9783,"price_display":"43.98","price_state":"stated","total_value":8697412.4778,"total_display":"8,697,412.48","total_whole":"8,697,412","shares_owned_after":7879374.0,"shares_owned_after_display":"7,879,374","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-02","filed_date":"2022-12-05","scope":"insider"},{"id":6604765,"accession":"0001140361-22-044471","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-22-044471","line_url":"/filing/0001140361-22-044471#line-1","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":null,"owner_name":"Avara Management Ltd; Giuliani Mario Germano; MGG Strategic SICAF SIF S.A.; MGG Strategic SICAF SIF S.A. - MGG Strategic; Skyeline Management Ltd","owner_display_name":"Avara Management Ltd","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":165000.0,"shares_display":"165,000","price_per_share":44.105,"price_display":"44.10","price_state":"stated","total_value":7277325.0,"total_display":"7,277,325.00","total_whole":"7,277,325","shares_owned_after":22225000.0,"shares_owned_after_display":"22,225,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-01","filed_date":"2022-12-05","scope":"insider"},{"id":6748426,"accession":"0001140361-22-034416","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-22-034416","line_url":"/filing/0001140361-22-034416#line-3","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":null,"owner_name":"Avara Management Ltd; Giuliani Mario Germano; MGG Strategic SICAF SIF S.A.; MGG Strategic SICAF SIF S.A. - MGG Strategic; Skyeline Management Ltd","owner_display_name":"Avara Management Ltd","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":125697.0,"shares_display":"125,697","price_per_share":41.253,"price_display":"41.25","price_state":"stated","total_value":5185378.341,"total_display":"5,185,378.34","total_whole":"5,185,378","shares_owned_after":8321113.0,"shares_owned_after_display":"8,321,113","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-09-21","filed_date":"2022-09-22","scope":"insider"},{"id":6748423,"accession":"0001140361-22-034416","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-22-034416","line_url":"/filing/0001140361-22-034416","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":null,"owner_name":"Avara Management Ltd; Giuliani Mario Germano; MGG Strategic SICAF SIF S.A.; MGG Strategic SICAF SIF S.A. - MGG Strategic; Skyeline Management Ltd","owner_display_name":"Avara Management Ltd","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":398145.0,"shares_display":"398,145","price_per_share":41.01815969056499,"price_display":"41.02","price_state":"stated","total_value":16331175.19,"total_display":"16,331,175.19","total_whole":"16,331,175","shares_owned_after":22390000.0,"shares_owned_after_display":"22,390,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-09-20","filed_date":"2022-09-22","scope":"insider","n_lines":2},{"id":6667124,"accession":"0001140361-22-034012","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-22-034012","line_url":"/filing/0001140361-22-034012#line-2","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":null,"owner_name":"Giuliani Mario Germano; MGG Strategic SICAF SIF S.A.; MGG Strategic SICAF SIF S.A. - MGG Strategic","owner_display_name":"Giuliani Mario Germano","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":232185.0,"shares_display":"232,185","price_per_share":41.5,"price_display":"41.50","price_state":"stated","total_value":9635677.5,"total_display":"9,635,677.50","total_whole":"9,635,678","shares_owned_after":22657815.0,"shares_owned_after_display":"22,657,815","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-09-19","filed_date":"2022-09-20","scope":"insider"},{"id":6667122,"accession":"0001140361-22-034012","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-22-034012","line_url":"/filing/0001140361-22-034012#line-1","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":null,"owner_name":"Giuliani Mario Germano; MGG Strategic SICAF SIF S.A.; MGG Strategic SICAF SIF S.A. - MGG Strategic","owner_display_name":"Giuliani Mario Germano","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":154986.0,"shares_display":"154,986","price_per_share":41.7208,"price_display":"41.72","price_state":"stated","total_value":6466139.9088,"total_display":"6,466,139.91","total_whole":"6,466,140","shares_owned_after":22890000.0,"shares_owned_after_display":"22,890,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-09-16","filed_date":"2022-09-20","scope":"insider"},{"id":6112680,"accession":"0001140361-22-033647","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-22-033647","line_url":"/filing/0001140361-22-033647#line-2","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":null,"owner_name":"Giuliani Mario Germano; MGG Strategic SICAF SIF S.A.; MGG Strategic SICAF SIF S.A. - MGG Strategic","owner_display_name":"Giuliani Mario Germano","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":154154.0,"shares_display":"154,154","price_per_share":42.2622,"price_display":"42.26","price_state":"stated","total_value":6514887.1788,"total_display":"6,514,887.18","total_whole":"6,514,887","shares_owned_after":23044986.0,"shares_owned_after_display":"23,044,986","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-09-15","filed_date":"2022-09-16","scope":"insider"},{"id":6112677,"accession":"0001140361-22-033647","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-22-033647","line_url":"/filing/0001140361-22-033647#line-1","is_derivative":false,"issuer_cik":"0001802768","issuer_name":"Royalty Pharma plc","issuer_ticker":"RPRX","issuer_name_source":null,"issuer_url":"/issuer/0001802768","owner_cik":null,"owner_name":"Giuliani Mario Germano; MGG Strategic SICAF SIF S.A.; MGG Strategic SICAF SIF S.A. - MGG Strategic","owner_display_name":"Giuliani Mario Germano","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":190860.0,"shares_display":"190,860","price_per_share":42.4816,"price_display":"42.48","price_state":"stated","total_value":8108038.176,"total_display":"8,108,038.18","total_whole":"8,108,038","shares_owned_after":23199140.0,"shares_owned_after_display":"23,199,140","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-09-14","filed_date":"2022-09-16","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001802768","name":"Royalty Pharma plc","url":"/issuer/0001802768","role":"Ten percent owner","n_filings":4,"first_seen":"2022-09-16","last_seen":"2022-12-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001922189","retrieved_at":"2026-08-23T01:53:16+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}